Cargando…

Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy

This study retrospectively investigated the effect of neuromuscular electrical stimulation (NMES) for fatigue management in patients with advanced laryngeal cancer (ALC) receiving chemoradiotherapy. A total of 60 eligible patients with ALC receiving chemoradiotherapy were included. These patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mei-jia, Mu, Ji-wei, Qu, Xiu-sheng, Feng, Chong, Zhao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076145/
https://www.ncbi.nlm.nih.gov/pubmed/29995774
http://dx.doi.org/10.1097/MD.0000000000011370
_version_ 1783344653330808832
author Zhang, Mei-jia
Mu, Ji-wei
Qu, Xiu-sheng
Feng, Chong
Zhao, Wei
author_facet Zhang, Mei-jia
Mu, Ji-wei
Qu, Xiu-sheng
Feng, Chong
Zhao, Wei
author_sort Zhang, Mei-jia
collection PubMed
description This study retrospectively investigated the effect of neuromuscular electrical stimulation (NMES) for fatigue management in patients with advanced laryngeal cancer (ALC) receiving chemoradiotherapy. A total of 60 eligible patients with ALC receiving chemoradiotherapy were included. These patients were assigned equally to a treatment group and a control group. Patients in the treatment group received NMES therapy and were treated for a total of 8 weeks, while the patients in the control group did not receive NMES therapy. The primary outcome was fatigue, measured by the multidimensional fatigue inventory (MFI). The secondary outcomes included anxiety and depression, measured by the Hospital Anxiety and Depression Scale (HADS), and sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI). All outcomes were evaluated before and after 8-week NMES treatment After 8-week NMES treatment, the patients in the treatment group did not exert better effect than patients in the control group in fatigue relief, measured by the MFI score, anxiety and depression decrease, assessed by HADS, and sleep quality improvement, evaluated by PSQI. The results of this study demonstrate that NMES may not benefit for fatigue relief in patients with ALC receiving chemoradiotherapy. Future studies should still focus on this topic and warrant these results.
format Online
Article
Text
id pubmed-6076145
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-60761452018-08-17 Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy Zhang, Mei-jia Mu, Ji-wei Qu, Xiu-sheng Feng, Chong Zhao, Wei Medicine (Baltimore) Research Article This study retrospectively investigated the effect of neuromuscular electrical stimulation (NMES) for fatigue management in patients with advanced laryngeal cancer (ALC) receiving chemoradiotherapy. A total of 60 eligible patients with ALC receiving chemoradiotherapy were included. These patients were assigned equally to a treatment group and a control group. Patients in the treatment group received NMES therapy and were treated for a total of 8 weeks, while the patients in the control group did not receive NMES therapy. The primary outcome was fatigue, measured by the multidimensional fatigue inventory (MFI). The secondary outcomes included anxiety and depression, measured by the Hospital Anxiety and Depression Scale (HADS), and sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI). All outcomes were evaluated before and after 8-week NMES treatment After 8-week NMES treatment, the patients in the treatment group did not exert better effect than patients in the control group in fatigue relief, measured by the MFI score, anxiety and depression decrease, assessed by HADS, and sleep quality improvement, evaluated by PSQI. The results of this study demonstrate that NMES may not benefit for fatigue relief in patients with ALC receiving chemoradiotherapy. Future studies should still focus on this topic and warrant these results. Wolters Kluwer Health 2018-07-13 /pmc/articles/PMC6076145/ /pubmed/29995774 http://dx.doi.org/10.1097/MD.0000000000011370 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Zhang, Mei-jia
Mu, Ji-wei
Qu, Xiu-sheng
Feng, Chong
Zhao, Wei
Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy
title Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy
title_full Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy
title_fullStr Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy
title_full_unstemmed Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy
title_short Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy
title_sort effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076145/
https://www.ncbi.nlm.nih.gov/pubmed/29995774
http://dx.doi.org/10.1097/MD.0000000000011370
work_keys_str_mv AT zhangmeijia effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy
AT mujiwei effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy
AT quxiusheng effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy
AT fengchong effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy
AT zhaowei effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy